Skip to main content
Hui-Kuo Shu, MD, Radiation Oncology, Atlanta, GA

Hui-KuoGeorgeShuMD

Radiation Oncology Atlanta, GA

Professor, Radiation Oncology, Emory University School of Medicine

Dr. Shu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Shu's full profile

Already have an account?

  • Office

    1365 Clifton Rd Ne
    CT-104
    Atlanta, GA 30322
    Phone+1 404-778-3473
    Fax+1 404-778-3670

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Residency, Radiation Oncology, 1994 - 1999
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 1993 - 1994
  • Case Western Reserve University School of Medicine
    Case Western Reserve University School of MedicineClass of 1993

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1995 - Present
  • GA State Medical License
    GA State Medical License 2005 - 2025
  • NJ State Medical License
    NJ State Medical License 2002 - 2007
  • PA State Medical License
    PA State Medical License 1999 - 2006
  • American Board of Radiology Radiation Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Fractionated Radiotherapy Is Associated with Lower Rates of Treatment-Related Edema Than Stereotactic Radiosurgery in MRI-Defined Meningiomas  
    Bree R Eaton, Ian R Crocker, Arif N Ali, Hui-Kuo G Shu, World Neurosurgery

Authored Content

  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain MetastasesApril 2018
  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018
  • Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Postoperative Stereotactic Radiosurgery to Resected Brain Metastases RelatedApril 2018

Press Mentions

  • Advanced 3D MRI Technology Marks a Leap Forward in Glioblastoma Imaging
    Advanced 3D MRI Technology Marks a Leap Forward in Glioblastoma ImagingMay 9th, 2016

Professional Memberships